Resources
About Us
Healthcare Artificial Intelligence Market by Offering (Software, Services), Technology (ML, NLP), Application (Hospital Workflow Management, Patient Management), End User (Hospitals & Diagnostic Centers), and Geography - Global Forecast to 2031
Report ID: MRICT - 104139 Pages: 230 Apr-2024 Formats*: PDF Category: Information and Communications Technology Delivery: 24 to 48 Hours Download Free Sample ReportThe growth of the healthcare artificial intelligence market is driven by the growing demand for personalized therapy, the rise in the volume and complexities associated with healthcare datasets, and the rising need to reduce healthcare costs. However, reluctance to adopt AI technologies due to a lack of trust restrains the growth of this market. Moreover, the growing potential of AI-based tools in the treatment of chronic and infectious diseases and the rising incorporation of AI in clinical trials to accelerate new drug launches are expected to generate market growth opportunities. However, discrepancies arising due to upgrades and human barriers to AI adoption are major challenges for market stakeholders. Additionally, growing AI-based clinical decision support systems (CDSS) to identify patient risk are prominent trends in this market.
Click here to: Get Free Sample Pages of this Report
Personalized therapy is an emerging practice of medicine that uses an individual's genetic profile to guide decisions made regarding the prevention, diagnosis, and treatment of disease. Personalized therapy is revolutionizing the healthcare industry, and the integration of artificial intelligence (AI) is fueling this transformation. AI technologies have significantly advanced ability to analyze vast amounts of complex data, leading to improved diagnosis and treatment outcomes. AI algorithms can process extensive patient data, including genetic information, medical records, and lifestyle factors, to create personalized treatment plans. By analyzing patterns and correlations within this data, AI can identify hidden insights and predict individual treatment responses with unprecedented accuracy.
However, with the growing adoption of AI in personalized therapy various companies are providing the solution for individuals to more effective treatment and better outcomes. For instance, in October 2021, Fujitsu Limited (Japan) partnered with Aichi Cancer Center (Japan) to develop an AI system to offer patients personalized cancer treatment. The new solution enables efficient and precise search of information in medical databases, contributing to a significant reduction of time required for physicians to plan individualized medical treatment for cancer patients. Such growing developments help to increase the demand for personalized therapy using AI which helps to increase the growth of this market during the forecast period.
Based on offering, the global healthcare artificial intelligence market is segmented into software, hardware, and services. The services segment is projected to register the highest CAGR during the forecast period. The rising use of AI services for personalized medication guidance and 24/7 support, the increasing need to analyze data to identify potential health issues, the rising adoption of AI services to help reduce human error, assist medical professionals and staff, and the growing incorporation of AI services in clinical trials to accelerate new drug launches are expected to support the growth of this segment.
Based on technology, the global healthcare artificial intelligence market is segmented into machine learning, natural language processing, context-aware processing, and querying method. The natural language processing segment is projected to register the highest CAGR during the forecast period. The increasing need to predict the risk of any health-related complication at an early stage, the increasing use of efficient back-end coding to optimize billing procedures, the growing ability to collect large amounts of data and handle big data, and the rising need to organize physician documentation are expected to support the growth of this segment.
Based on Application, the Hospital Workflow Management Segment to Register the Highest CAGR in the Healthcare Artificial Intelligence Market
Based on application, the global healthcare artificial intelligence market is segmented into drug discovery, hospital workflow management, patient data & risk analytics, medical imaging & diagnosis, patient management, precision medicine, and other applications. The hospital workflow management segment is projected to register the highest CAGR during the forecast period. The increasing use of AI in hospitals to improve patient experience and to provide better care to their patient, the growing amount of healthcare data generated to manage medical records and assemble and evaluate patient data generated in the hospitals, the growing adoption to automate tasks, improve patient care coordination, reduce costs, and the increasing use of chatbots for customer service engagement are expected to support the growth of this segment.
Based on End User, the Hospitals & Diagnostic Centers Segment to Register the Highest CAGR in the Healthcare Artificial Intelligence Market
Based on end user, the global healthcare artificial intelligence market is segmented into hospitals & diagnostic centers, pharmaceutical & biotechnology companies, healthcare payers, patients, and other end users. The hospitals & diagnostic centers segment is projected to register the highest CAGR during the forecast period. The growing adoption of AI to improve accuracy, reduce costs, and save time compared to traditional diagnostic methods, the rising use of AI for automating routine tasks such as maintaining records, data entry, and scan analysis, and the growing need to improve the speed and accuracy of patient visits, leading to faster and more personalized care are expected to support the growth of this segment.
In 2024, North America is expected to account for the largest share of the market in the global healthcare artificial intelligence market. However, the Asia-Pacific market is projected to register the highest CAGR during the forecast period. The significant use of big data in the healthcare sector, the growing need for coordination between healthcare workforce & patients, the rise in adoption of precision medicine, the growing prevalence of diseases and remarkable growth in venture capital investments, and the rising technological innovation are expected to support the growth of this market.
The report includes a competitive landscape based on an extensive assessment of the key growth strategies adopted by leading market participants in the last 3–4 years. The key players operating in the healthcare artificial intelligence market are NVIDIA Corporation (U.S.), Google LLC (U.S.) (A Subsidiary of Alphabet Inc.), Intel Corporation (U.S.), International Business Machines Corporation (U.S.), Microsoft Corporation (U.S.), GE HealthCare Technologies Inc. (U.S.), Amazon.com, Inc. (U.S.), Verint Systems Inc. (U.S.), General Vision, Inc. (U.S.), Siemens Healthineers AG (Germany), CloudMedx Inc. (U.S.), AltexSoft Inc. (U.S.), IQVIA Holdings Inc. (U.S.), Welltok, Inc. (U.S.), and iCarbonX (China).
Particular |
Details |
Number of Pages |
230 |
Format |
|
Forecast Period |
2024-2031 |
Base Year |
2022 |
CAGR |
31.3% |
Estimated Market Size (Value) |
$176.4 billion by 2031 |
Segments Covered |
By Offering
By Technology
By Application
By End User
|
Countries Covered |
North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, RoE), Asia-Pacific (China, Japan, India, Singapore, South Korea, RoAPAC), Latin America, and the Middle East & Africa. |
Key Companies |
NVIDIA Corporation (U.S.), Google LLC (U.S.) (A Subsidiary of Alphabet Inc.), Intel Corporation (U.S.), International Business Machines Corporation (U.S.), Microsoft Corporation (U.S.), GE HealthCare Technologies Inc. (U.S.), Amazon.com, Inc. (U.S.), Verint Systems Inc. (U.S.), General Vision, Inc. (U.S.), Siemens Healthineers AG (Germany), CloudMedx Inc. (U.S.), AltexSoft Inc. (U.S.), IQVIA Holdings Inc. (U.S.), Welltok, Inc. . (U.S.), and iCarbonX (China). |
Key questions answered in the report:
The global healthcare artificial intelligence market is projected to reach $176.4 Billion by 2031, at a CAGR of 31.3% during the forecast period.
In 2024, the hospital workflow management segment is expected to account for the largest share of the global healthcare artificial intelligence market. This segment's large market share is attributed to the growing amount of healthcare data generated to manage medical records and assemble and evaluate patient data generated in hospitals, the increasing use of chatbots for customer service engagement, the growing adoption of automated tasks, improved patient care coordination, reduced costs, and the increasing use of AI in hospitals to improve patient experience and care.
The growth of the healthcare artificial intelligence market is driven by the growing demand for personalized therapy, the rise in the volume and complexities associated with healthcare datasets, and the rising need to reduce healthcare costs. Moreover, the growing potential of AI-based tools in the treatment of chronic and infectious diseases and the rising incorporation of AI in clinical trials to accelerate new drug launches are expected to generate market growth opportunities.
The key players operating in the healthcare artificial intelligence market are NVIDIA Corporation (U.S.), Google LLC (U.S.) (A Subsidiary of Alphabet Inc.), Intel Corporation (U.S.), International Business Machines Corporation (U.S.), Microsoft Corporation (U.S.), GE HealthCare Technologies Inc. (U.S.), Amazon.com, Inc. (U.S.), Verint Systems Inc. (U.S.), General Vision, Inc. (U.S.), Siemens Healthineers AG (Germany), CloudMedx Inc. (U.S.), AltexSoft Inc. (U.S.), IQVIA Holdings Inc. (U.S.), Welltok, Inc. (U.S.), and iCarbonX (China).
Published Date: Oct-2024
Please enter your corporate email id here to view sample report.
Subscribe to get the latest industry updates